Access to medicines for rare diseases: A European regulatory roadmap for academia
Background: Novel or repurposed medicines for rare diseases often emerge from fundamental research or empirical findings in academia. However, researchers may be insufficiently aware of the possibilities and requirements to bring novel medicinal treatment options to the patient. This paper aims to p...
Saved in:
Main Authors: | Noa Rosenberg (Author), Sibren van den Berg (Author), Nina N. Stolwijk (Author), Bart A. W. Jacobs (Author), Hendrika C. Post (Author), Anna M. G. Pasmooij (Author), Saco J. de Visser (Author), Carla E. M. Hollak (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Repurposing for Rare Diseases: A Role for Academia
by: Sibren van den Berg, et al.
Published: (2021) -
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects
by: Yasmin Polak, et al.
Published: (2023) -
Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patients
by: Natalja Bouwhuis, et al.
Published: (2023) -
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid
by: Yasmin Polak, et al.
Published: (2021) -
Assessing Changes in Fear of Movement in Patients attending Cardiac Rehabilitation: Responsiveness of the TSK-NL Heart Questionnaire
by: Nienke ter Hoeve, et al.
Published: (2022)